Intergenetics is now Medicover Genetics

InterGenetics Center for Medical Genetics and Genomics is excited to announce its official renaming to Medicover Genetics. Following its acquisition by Medicover, a leading international healthcare and diagnostic services company, InterGenetics officially adopts the Medicover brand. This strategic move reflects the company’s evolution as a longstanding and respected provider of genetic services in Greece.

By adopting its new identity, Medicover Genetics (formerly InterGenetics) proudly joins the Medicover international network, a community of accomplished professionals united by common goals, values and determination to expand access to cutting-edge genetic services and place genetics at the core of medical decisions.

Medicover Genetics remains committed to delivering exceptional customer service to its partners, associates, doctors and patients whose valued trust over the years signifies the successful pursuit of the Company's objectives. The rebranding involves the change of the company’s name, and the brand’s aesthetics. The G.E.MI. registration number of the company, and its respective VAT number remain the same.

Dr. Voula Velissariou, Scientific & Managing Director of Medicover Genetics, stated that, "As we embark on this exciting brand transformation, our foundations remain rooted in innovation and quality services. The new identity of Medicover Genetics is not just aesthetic; it is a promise to stay at the forefront of genetic discovery and integrate these advancements into clinical care. Our new brand will reflect the caliber of our services, reinforcing our essential role in the medical community and in the lives of those we serve".

The process of transitioning to the new brand, look and identity is already underway and is expected to be completed within the next few months. Medicover Genetics looks forward to continuing its legacy of providing exceptional genetic services and contributing to advancements in medical care.

For more information contact:
Pepa Tanousis
Marketing and Communications Director, Medicover Genetics
[email protected]

About Medicover Genetics

Medicover Genetics is a leading healthcare company specialising in genetic medicine, with more than 25 years of experience in genetics diagnostics. Medicover Genetics offers genetic testing services and genetic counselling, proprietary CE-IVD marked solutions and a versatile Technology Transfer Platform which enables partners to perform high fidelity genetic tests in-house. With services in over 30 countries across Europe, Asia, and Africa, the company empowers laboratories, healthcare professionals and patients to place genetics at the core of medical decisions. Committed to enhancing health and well-being, Medicover Genetics provides meaningful, actionable diagnostic solutions, improving disease prognosis, clinical management, and therapy selection for genetic disorders. The CAP-accredited, CLIA-, GMP- and ISO9001, 15189, and 13485 certified laboratories ensure the highest quality standards.
Medicover Genetics is part of Medicover, a leading international healthcare and diagnostic services company founded in 1995 and listed on Nasdaq Stockholm.

Η Εθνική Ακαδημία Ιατρικής της Γαλλίας στη συνεδρίαση της 29ης Μαρτίου 2016 εξέλεξε αντεπιστέλλον μέλος της τον Καθηγητή Ιατρικής Γενετικής κ. Κωνσταντίνο Γ. Πάγκαλο, Ιδρυτή, Επιστημονικό Διευθυντή (CSO) και Διευθύνοντα Σύμβουλο (CEO) της InterGenetics

Δημοσίευση στις 26 Απριλίου 2016 στο περιοδικό Peer J , επιστημονικής εργασίας που αφορά το νέο γενωμικό τεστ Fetalis…

Προφορική παρουσίαση (oral communication) του Καθ. Κωνσταντίνου Γ. Πάγκαλου, με θέμα: ‘A prenatal targeted exome sequencing approach Fetalis designed specifically for fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects’

Ομιλία του Καθ. Κωνσταντίνου Γ. Πάγκαλου με θέμα: ‘Invasive vs non-invasive prenatal genetic diagnosis’